Post-translational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory–autoimmunity connection

Maurizio Bruschi, Andrea Petretto, Roberta Bertelli, Maricla Galetti, Alice Bonanni, Federico Pratesi, Paola Migliorini, Giovanni Candiano, Augusto Vaglio, Gian Marco Ghiggeri

Research output: Contribution to journalReview article

3 Citations (Scopus)

Abstract

Basic research is showing new mechanisms involved in early immune responses and Neutrophil Extracellular Trap (NET) formation (or NETosis) is of key importance as first line defense against bacteria, virus and protozoa. Enzymatic modification of arginine in citrulline in histones is the prerequisite of NETosis being it necessary for decondensation and extrusion of DNA from cells; it is conceivable that other post translational modifications may occur during this event. There is consensus in considering that post translational modified proteins may elicit an autoimmune response that leads to the formation of autoantibodies. Several autoimmune diseases seem to share these pathogenic mechanisms, in particular Rheumatoid arthritis, Systemic Lupus Erythematosus, Small Vessel Vasculitis and Anti-Phospholipid Syndrome, which are all characterized by high levels of circulating autoantibodies. Autoimmunity has, however, different targets and elicits different clinical responses. It seems reasonable to hypothesize that although NETosis is common to all the conditions above, NET components are different and potentially responsible for different autoimmune responses. On the other hand also showing whether circulating NET remnants are present as free structures in blood/biological fluids and determine their levels is relevant to autoimmunity. This review is intended to discuss the rationale for utilizing new discoveries that could be of rapid clinical application and lead to the development of early biomarkers of autoimmunity to predict and treat otherwise serious conditions.

Original languageEnglish
Pages (from-to)12-16
Number of pages5
JournalClinica Chimica Acta
Volume464
DOIs
Publication statusPublished - Jan 1 2017

Fingerprint

Biomarkers
Autoimmunity
Autoantibodies
Protozoa
Citrulline
Viruses
Histones
Extrusion
Arginine
Phospholipids
Bacteria
Proteins
Blood
Fluids
DNA
Antiphospholipid Syndrome
Post Translational Protein Processing
Vasculitis
Systemic Lupus Erythematosus
Autoimmune Diseases

Keywords

  • Autoantibodies
  • Autoimmunity
  • Carbamylation
  • Citrullinated proteins
  • Neutrophil extracellular traps

ASJC Scopus subject areas

  • Biochemistry
  • Clinical Biochemistry
  • Biochemistry, medical

Cite this

Post-translational modified proteins are biomarkers of autoimmune-processes : NETosis and the inflammatory–autoimmunity connection. / Bruschi, Maurizio; Petretto, Andrea; Bertelli, Roberta; Galetti, Maricla; Bonanni, Alice; Pratesi, Federico; Migliorini, Paola; Candiano, Giovanni; Vaglio, Augusto; Ghiggeri, Gian Marco.

In: Clinica Chimica Acta, Vol. 464, 01.01.2017, p. 12-16.

Research output: Contribution to journalReview article

@article{bace6856344a4b17aa8431c166b4b33c,
title = "Post-translational modified proteins are biomarkers of autoimmune-processes: NETosis and the inflammatory–autoimmunity connection",
abstract = "Basic research is showing new mechanisms involved in early immune responses and Neutrophil Extracellular Trap (NET) formation (or NETosis) is of key importance as first line defense against bacteria, virus and protozoa. Enzymatic modification of arginine in citrulline in histones is the prerequisite of NETosis being it necessary for decondensation and extrusion of DNA from cells; it is conceivable that other post translational modifications may occur during this event. There is consensus in considering that post translational modified proteins may elicit an autoimmune response that leads to the formation of autoantibodies. Several autoimmune diseases seem to share these pathogenic mechanisms, in particular Rheumatoid arthritis, Systemic Lupus Erythematosus, Small Vessel Vasculitis and Anti-Phospholipid Syndrome, which are all characterized by high levels of circulating autoantibodies. Autoimmunity has, however, different targets and elicits different clinical responses. It seems reasonable to hypothesize that although NETosis is common to all the conditions above, NET components are different and potentially responsible for different autoimmune responses. On the other hand also showing whether circulating NET remnants are present as free structures in blood/biological fluids and determine their levels is relevant to autoimmunity. This review is intended to discuss the rationale for utilizing new discoveries that could be of rapid clinical application and lead to the development of early biomarkers of autoimmunity to predict and treat otherwise serious conditions.",
keywords = "Autoantibodies, Autoimmunity, Carbamylation, Citrullinated proteins, Neutrophil extracellular traps",
author = "Maurizio Bruschi and Andrea Petretto and Roberta Bertelli and Maricla Galetti and Alice Bonanni and Federico Pratesi and Paola Migliorini and Giovanni Candiano and Augusto Vaglio and Ghiggeri, {Gian Marco}",
year = "2017",
month = "1",
day = "1",
doi = "10.1016/j.cca.2016.11.006",
language = "English",
volume = "464",
pages = "12--16",
journal = "Clinica Chimica Acta",
issn = "0009-8981",
publisher = "Elsevier",

}

TY - JOUR

T1 - Post-translational modified proteins are biomarkers of autoimmune-processes

T2 - NETosis and the inflammatory–autoimmunity connection

AU - Bruschi, Maurizio

AU - Petretto, Andrea

AU - Bertelli, Roberta

AU - Galetti, Maricla

AU - Bonanni, Alice

AU - Pratesi, Federico

AU - Migliorini, Paola

AU - Candiano, Giovanni

AU - Vaglio, Augusto

AU - Ghiggeri, Gian Marco

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Basic research is showing new mechanisms involved in early immune responses and Neutrophil Extracellular Trap (NET) formation (or NETosis) is of key importance as first line defense against bacteria, virus and protozoa. Enzymatic modification of arginine in citrulline in histones is the prerequisite of NETosis being it necessary for decondensation and extrusion of DNA from cells; it is conceivable that other post translational modifications may occur during this event. There is consensus in considering that post translational modified proteins may elicit an autoimmune response that leads to the formation of autoantibodies. Several autoimmune diseases seem to share these pathogenic mechanisms, in particular Rheumatoid arthritis, Systemic Lupus Erythematosus, Small Vessel Vasculitis and Anti-Phospholipid Syndrome, which are all characterized by high levels of circulating autoantibodies. Autoimmunity has, however, different targets and elicits different clinical responses. It seems reasonable to hypothesize that although NETosis is common to all the conditions above, NET components are different and potentially responsible for different autoimmune responses. On the other hand also showing whether circulating NET remnants are present as free structures in blood/biological fluids and determine their levels is relevant to autoimmunity. This review is intended to discuss the rationale for utilizing new discoveries that could be of rapid clinical application and lead to the development of early biomarkers of autoimmunity to predict and treat otherwise serious conditions.

AB - Basic research is showing new mechanisms involved in early immune responses and Neutrophil Extracellular Trap (NET) formation (or NETosis) is of key importance as first line defense against bacteria, virus and protozoa. Enzymatic modification of arginine in citrulline in histones is the prerequisite of NETosis being it necessary for decondensation and extrusion of DNA from cells; it is conceivable that other post translational modifications may occur during this event. There is consensus in considering that post translational modified proteins may elicit an autoimmune response that leads to the formation of autoantibodies. Several autoimmune diseases seem to share these pathogenic mechanisms, in particular Rheumatoid arthritis, Systemic Lupus Erythematosus, Small Vessel Vasculitis and Anti-Phospholipid Syndrome, which are all characterized by high levels of circulating autoantibodies. Autoimmunity has, however, different targets and elicits different clinical responses. It seems reasonable to hypothesize that although NETosis is common to all the conditions above, NET components are different and potentially responsible for different autoimmune responses. On the other hand also showing whether circulating NET remnants are present as free structures in blood/biological fluids and determine their levels is relevant to autoimmunity. This review is intended to discuss the rationale for utilizing new discoveries that could be of rapid clinical application and lead to the development of early biomarkers of autoimmunity to predict and treat otherwise serious conditions.

KW - Autoantibodies

KW - Autoimmunity

KW - Carbamylation

KW - Citrullinated proteins

KW - Neutrophil extracellular traps

UR - http://www.scopus.com/inward/record.url?scp=84994704854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84994704854&partnerID=8YFLogxK

U2 - 10.1016/j.cca.2016.11.006

DO - 10.1016/j.cca.2016.11.006

M3 - Review article

AN - SCOPUS:84994704854

VL - 464

SP - 12

EP - 16

JO - Clinica Chimica Acta

JF - Clinica Chimica Acta

SN - 0009-8981

ER -